Brief: Beam Therapeutics - Strong Balance Sheet Provides Anticipated Operating Runway Into Second Half 2026

Beam Therapeutics

08/11/2023 11:33

Nov 8 (Reuters) - Beam Therapeutics Inc  BEAM.O :
    * STRONG BALANCE SHEET PROVIDES ANTICIPATED OPERATING RUNWAY
INTO
SECOND HALF OF 2026
    * BEAM THERAPEUTICS - CASH, CASH EQUIVALENTS AND MARKETABLE
SECURITIES, EXCLUDING UPFRONT PROCEEDS FROM LILLY, WERE $1.0
BILLION AS OF SEPTEMBER 30, 2023
    * : STRONG BALANCE SHEET PROVIDES ANTICIPATED OPERATING
RUNWAY
INTO SECOND HALF OF 2026
    * QTRLY LOSS PER SHARE $1.22
    * Q3 EARNINGS PER SHARE VIEW $-1.36 -- LSEG IBES DATA

Source text for Eikon:  ID:nGNX5zQBHM 
Further company coverage:  BEAM.O 

 ((Reuters.Briefs@thomsonreuters.com;))